12 Month Price Forecast For IPX
Distance to IPX Price Forecasts
IPX Price Momentum
๐ค Considering IperionX (IPX)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 8, 2025 3:49 AM UTC
IPX Analyst Ratings & Price Targets
Based on our analysis of 3 Wall Street analysts, IPX has a consensus that is bullish. The median price target is $30.00, with forecasts ranging from $20.00 to $32.00. Currently, there are 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With IPX currently trading at $26.26, the median price forecast suggests a 14.2% upside. The most optimistic forecast comes from at , projecting a 21.9% upside, while Ashok Kumar at ThinkEquity provides the most conservative target, suggesting a -23.8% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
IPX Analyst Consensus
IPX Price Target Range
Latest IPX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for IPX.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Oct 10, 2024 | B. Riley Securities | Lucas Pipes | Buy | Initiates | $30.00 |
Jun 24, 2024 | ThinkEquity | Ashok Kumar | Buy | Initiates | $20.00 |
Dec 8, 2022 | Alliance Global Partners | Jake Sekelsky | Buy | Initiates | $16.50 |
Stocks Similar to IperionX Limited
The following stocks are similar to IperionX based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
IperionX Limited (IPX) Financial Data
IperionX Limited has a market capitalization of $791.76M with a P/E ratio of -26.3x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -60.8%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

IperionX Limited (IPX) Company Overview
About IperionX Limited
Explores and develops critical mineral resources.
The company generates revenue through the exploration and development of its mineral properties, primarily focusing on titanium, rare earth elements, and zircon. IperionX operates a titanium production facility that recycles scrap titanium to create products for diverse industries such as aerospace, defense, and consumer electronics.
IperionX holds a significant mineral resource in Tennessee, covering over 11,000 acres, and has rebranded from Hyperion Metals Limited in 2022. Established in 2017, the company is headquartered in Charlotte, North Carolina, positioning itself strategically within the growing demand for critical minerals.
Company Information
Sector
Basic Materials
Industry
Other Industrial Metals & Mining
Employees
0
CEO
Mr. Anastasios Arima B.Com.
Country
United States
IPO Year
2022
Website
iperionx.comIperionX Limited (IPX) Latest News & Analysis
IperionX Letter to Shareholders
1 day agoIperionX has issued a letter to shareholders, detailing updates and insights related to the company's operations and performance.
The letter to shareholders may indicate IperionX's strategic direction and financial health, influencing investor sentiment and stock performance.
IperionX December 2024 Quarterly Report
10 days agoIperionX has released its quarterly report for December 2024, providing updates on financial performance and business developments.
The quarterly report from IperionX may provide insights into financial health and performance, influencing stock valuation and investment decisions.
IperionX has successfully completed its acquisition of breakthrough titanium technologies, enhancing its capabilities in the titanium market.
IPERIONX's acquisition enhances its competitive edge in titanium technologies, potentially increasing market share and driving future growth, impacting stock performance and investor interest.
IperionX Achieves Major Milestone With First Successful Titanium Furnace Production Run
5 months agoIPERIONX has successfully completed its first titanium furnace production run, marking a significant milestone for the company in its operations.
IperionX's successful titanium furnace production run indicates progress in innovative manufacturing, potentially enhancing market competitiveness and attracting investment interest.
IperionX and Aperam have formed a partnership aimed at developing a circular titanium supply chain, enhancing sustainability in titanium production.
The partnership between IperionX and Aperam signals innovation in the titanium supply chain, potentially enhancing sustainability and reducing costs, which could boost their competitiveness and attract investment.
IperionX and Vegas Fastener will co-produce titanium fasteners for the U.S. Army, enhancing their collaboration in the defense sector.
The partnership between IperionX and Vegas Fastener to produce titanium fasteners for the U.S. Army signals strong demand and potential revenue growth, enhancing investor confidence in both companies.
Frequently Asked Questions About IPX Stock
What is IperionX Limited's (IPX) stock forecast for 2025?
Based on our analysis of 3 Wall Street analysts, IperionX Limited (IPX) has a median price target of $30.00. The highest price target is $32.00 and the lowest is $20.00.
Is IPX stock a good investment in 2025?
According to current analyst ratings, IPX has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $26.26. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for IPX stock?
Wall Street analysts predict IPX stock could reach $30.00 in the next 12 months. This represents a 14.2% increase from the current price of $26.26. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is IperionX Limited's business model?
The company generates revenue through the exploration and development of its mineral properties, primarily focusing on titanium, rare earth elements, and zircon. IperionX operates a titanium production facility that recycles scrap titanium to create products for diverse industries such as aerospace, defense, and consumer electronics.
What is the highest forecasted price for IPX IperionX Limited?
The highest price target for IPX is $32.00 from at , which represents a 21.9% increase from the current price of $26.26.
What is the lowest forecasted price for IPX IperionX Limited?
The lowest price target for IPX is $20.00 from Ashok Kumar at ThinkEquity, which represents a -23.8% decrease from the current price of $26.26.
What is the overall IPX consensus from analysts for IperionX Limited?
The overall analyst consensus for IPX is bullish. Out of 3 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $30.00.
How accurate are IPX stock price projections?
Stock price projections, including those for IperionX Limited, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.